نتایج جستجو برای: cord blood stem cell transplantation

تعداد نتایج: 2459825  

Elham Rahmanipour, Negin Khatibzadeh,

Traumatic brain injury (TBI) leading to 5 million deaths annually is 1 of the 5 major causes of morbidity and mortality worldwide. In Iran, accidents are the main cause of death in youth as well as a dominant factor in reducing quality of life. In developing countries TBI incidence as one of the worst consequences of these accidents is growing due to wide use of motor-vehicles. Therapeutic stra...

2012
Sheeba Afreen Tulika Chandra Ashutosh Kumar Uma Singh Ashish Gupta

Umbilical cord blood (UCB) transplantation is being used as an alternative source of haematopoietic stem cells for bone marrow reconstitution. Umbilical cord blood (UCB) transplantation is being used as an alternative source of haematopoietic stem cells for bone marrow reconstitution. Separation and processing of UCB samples in large numbers for storage in cord blood banks ideally needs to be p...

Journal: :Haematologica 2011
Michelle Furtado Simon Rule

Effect of graft source on unrelated donor haemopoietic stem-cell trans-plantation in adults with acute leukaemia: a retrospective analysis. al. Unrelated transplantation for poor-prognosis adult acute lym-phoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source. R, et al. Favorable outcome of unrelated cord blood transplantation for Philadelphia chro...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran seyyedasadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hamdi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

post-remission treatment in patients with acute myeloid leukemia is still controversial. one potent choice for patients with no donor available is autologous stem cell transplantation. the median follow-up period was 18 months and the median age was 26 years old. in the review of 116 recently diagnosed aml patients (except aml- m3) who underwent autologous stem cell transplantation, 72.4% of pa...

Journal: :مجله علوم اعصاب شفای خاتم 0
maryam borhani-haghighi a. shefa neuroscience research center, khatam alanbia hospital, tehran, iran b. department of anatomy, tehran university of medical sciences, tehran, iran sara abdolahi a. shefa neuroscience research center, khatam alanbia hospital, tehran, iran b. department of anatomy, tehran university of medical sciences, tehran, iran sedigheh ghasemi shefa neuroscience research center, khatam alanbia hospital, tehran, iran

in worldwide, an estimated 40 cases per 1 million people reported with new spinal cord injuries each year. people with spinal cord injuries suffer from severe physical, psychological, social and economic problems. damaged or lost cells can't be replaced when the spinal cord is injured; therefore, its function becomes disturbed permanently. despite the significant advances in the understand...

Journal: :مجله علوم اعصاب شفای خاتم 0
hassan hoseini ravandi shefa neuroscience research center, khatam alanbia hospital, tehran, iran maryam borhani-haghighi shefa neuroscience research center, khatam alanbia hospital, tehran, iran

it was estimated that 3 million people suffered from spinal cord injury. unfortunately up to date, there are not any reliable clinical treatments for spinal cord injury and researches for treatments of sci have focused on medication, surgery, stem cell transplantation, molecular therapy and tissue engineering. also scientists are trying to use a combination of stem cells and nanotechnology scie...

Objective(s): Neurotrophic factors secreting cells (NTS-SCs) may be a superior cell source for cell-based therapy in neurodegenerative diseases. NTS-SCs are able to secrete some neurotrophic Such as nerve growth factor and glia-derived neurotrophic factor. Our primary aim was to assess transplantation of neurotrophic factor secreting cells derived from human adipose-derived stem cells (hADSCs) ...

Journal: :The New England journal of medicine 2011
Dirk van Bekkum Jaak Vossen Chris Zurcher

BACKGROUND Diarrhea is a frequent complication of hematopoietic stem-cell transplantation (HSCT). Important causes of diarrhea after HSCT include acute graft-versus-host disease (GVHD), infections, and medications. After the transplantation and engraftment of hematopoietic stem cells from umbilical-cord blood, we observed a new syndrome of culture-negative, antibiotic-responsive diarrhea not at...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید